Skip to main content
Top
Published in: Pediatric Nephrology 11/2023

10-04-2023 | Hantavirus | Brief Report

Favorable course of leptospirosis and hantavirus-induced acute tubulointerstitial nephritis under corticosteroid treatment

Authors: Annelies Matthys, Jo Dehoorne, Amélie Dendooven, Petra Schelstraete, Agnieszka Prytuła

Published in: Pediatric Nephrology | Issue 11/2023

Login to get access

Abstract

Background

We present two children with acute tubulointerstitial nephritis (ATIN) caused by leptospirosis in a 12-year-old boy and hantavirus in a 10-year-old girl. The role of glucocorticoids in the management of ATIN triggered by infectious agents is unclear.

Case-diagnosis/treatment

Both children were hospitalized with jaundice, elevated serum creatinine, and thrombocytopenia. There was no oliguria or hypertension. Urine analysis revealed tubular proteinuria. Kidney biopsy was performed on one patient and showed tubulointerstitial inflammation with mild mesangial proliferation. Both patients were treated with glucocorticoids in view of deteriorating kidney function with respective serum creatinine values of 5.2 and 4.1 mg/dl. Both children exhibited an excellent clinical and biochemical response to treatment. Neither of the patients required dialysis. Positive serology test results indicated a recent leptospirosis and hantavirus infection.

Conclusions

Leptospirosis and hantavirus associated ATIN share common clinical and biochemical features. Due to the low incidence in Europe these infectious causes of kidney dysfunction may be overlooked. Glucocorticoids may be considered in the management of ATIN.
Literature
1.
go back to reference Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A, Aoun B (2012) Acute tubulointerstitial nephritis. Pediatr Nephrol 27:1051–1057CrossRefPubMed Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A, Aoun B (2012) Acute tubulointerstitial nephritis. Pediatr Nephrol 27:1051–1057CrossRefPubMed
2.
3.
go back to reference Dusek J, Pejcoch M, Kolsky A, Seeman T, Nemec V, Stejskal J, Vondrak K, Janda J (2006) Mild course of Puumala nephropathy in children in an area with sporadic occurrence Hantavirus infection. Pediatr Nephrol 21:1889–1892CrossRefPubMed Dusek J, Pejcoch M, Kolsky A, Seeman T, Nemec V, Stejskal J, Vondrak K, Janda J (2006) Mild course of Puumala nephropathy in children in an area with sporadic occurrence Hantavirus infection. Pediatr Nephrol 21:1889–1892CrossRefPubMed
4.
go back to reference Bakelants E, Peetermans W, Lagrou K, Meersseman W (2020) Clinical and biochemical differences between hantavirus infection and leptospirosis: a retrospective analysis of a patient series in Belgium. Acta Clin Belg 75:185–192CrossRefPubMed Bakelants E, Peetermans W, Lagrou K, Meersseman W (2020) Clinical and biochemical differences between hantavirus infection and leptospirosis: a retrospective analysis of a patient series in Belgium. Acta Clin Belg 75:185–192CrossRefPubMed
5.
6.
go back to reference Martinuč Bergoč M, Lindič J, Kovač D, Ferluga D, Pajek J (2013) Successful treatment of severe hantavirus nephritis with corticosteroids: a case report and literature review. Ther Apher Dial 17:402–406CrossRefPubMed Martinuč Bergoč M, Lindič J, Kovač D, Ferluga D, Pajek J (2013) Successful treatment of severe hantavirus nephritis with corticosteroids: a case report and literature review. Ther Apher Dial 17:402–406CrossRefPubMed
7.
go back to reference Yang CW (2018) Leptospirosis renal disease: emerging culprit of chronic kidney disease unknown etiology. Nephron 138:129–136CrossRefPubMed Yang CW (2018) Leptospirosis renal disease: emerging culprit of chronic kidney disease unknown etiology. Nephron 138:129–136CrossRefPubMed
9.
go back to reference Clarkson MR, Giblin L, O’Connell FP, O’Kelly P, Walshe JJ, Conlon P, O’Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19:2778–2783CrossRefPubMed Clarkson MR, Giblin L, O’Connell FP, O’Kelly P, Walshe JJ, Conlon P, O’Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19:2778–2783CrossRefPubMed
10.
go back to reference González E, Gutiérrez E, Galeano C, Chevia C, de Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernández Y, Segovia B, Praga M (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940–946CrossRefPubMed González E, Gutiérrez E, Galeano C, Chevia C, de Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernández Y, Segovia B, Praga M (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940–946CrossRefPubMed
11.
go back to reference Jahnukainen T, Saarela V, Arikoski P, Ylinen E, Rönnholm K, Ala-Houhala M, Nuutinen M (2013) Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 28:1253–1260CrossRefPubMed Jahnukainen T, Saarela V, Arikoski P, Ylinen E, Rönnholm K, Ala-Houhala M, Nuutinen M (2013) Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 28:1253–1260CrossRefPubMed
12.
go back to reference Minor K, Mohan A (2013) Severe leptospirosis: treatment with intravenous corticosteroids and supportive care. Am J Emerg Med 31:449.e441-e442CrossRef Minor K, Mohan A (2013) Severe leptospirosis: treatment with intravenous corticosteroids and supportive care. Am J Emerg Med 31:449.e441-e442CrossRef
13.
go back to reference Tapia M, Mansilla C, Jose T, Vera M (2000) Hantavirus pulmonary syndrome, clinical experience in diagnosis and treatment. Hospital Coyhaique-Chile Rev Chil Infect 17:258–269 Tapia M, Mansilla C, Jose T, Vera M (2000) Hantavirus pulmonary syndrome, clinical experience in diagnosis and treatment. Hospital Coyhaique-Chile Rev Chil Infect 17:258–269
14.
go back to reference Vial PA, Valdivieso F, Ferres M, Riquelme R, Rioseco ML, Calvo M, Castillo C, Díaz R, Scholz L, Cuiza A, Belmar E, Hernandez C, Martinez J, Lee SJ, Mertz GJ (2013) High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis 57:943–951CrossRefPubMedPubMedCentral Vial PA, Valdivieso F, Ferres M, Riquelme R, Rioseco ML, Calvo M, Castillo C, Díaz R, Scholz L, Cuiza A, Belmar E, Hernandez C, Martinez J, Lee SJ, Mertz GJ (2013) High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis 57:943–951CrossRefPubMedPubMedCentral
15.
go back to reference Lupuşoru G, Lupuşoru M, Ailincăi I, Bernea L, Berechet A, Spătaru R, Ismail G (2021) Hanta hemorrhagic fever with renal syndrome: a pathology in whose diagnosis kidney biopsy plays a major role (Review). Exp Ther Med 22:984CrossRefPubMedPubMedCentral Lupuşoru G, Lupuşoru M, Ailincăi I, Bernea L, Berechet A, Spătaru R, Ismail G (2021) Hanta hemorrhagic fever with renal syndrome: a pathology in whose diagnosis kidney biopsy plays a major role (Review). Exp Ther Med 22:984CrossRefPubMedPubMedCentral
16.
go back to reference Reis EA, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR, Shaw AC, Ko AI, Reis MG (2013) Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis 7:e2457CrossRefPubMedPubMedCentral Reis EA, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR, Shaw AC, Ko AI, Reis MG (2013) Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis 7:e2457CrossRefPubMedPubMedCentral
18.
go back to reference Rodrigo C, Lakshitha de Silva N, Goonaratne R, Samarasekara K, Wijesinghe I, Parththipan B, Rajapakse S (2014) High dose corticosteroids in severe leptospirosis: a systematic review. Trans R Soc Trop Med Hyg 108:743–750CrossRefPubMed Rodrigo C, Lakshitha de Silva N, Goonaratne R, Samarasekara K, Wijesinghe I, Parththipan B, Rajapakse S (2014) High dose corticosteroids in severe leptospirosis: a systematic review. Trans R Soc Trop Med Hyg 108:743–750CrossRefPubMed
19.
go back to reference Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Kööbi T, Vaheri AI, Pasternack AI, Pörsti IH, Mustonen JT (2006) Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int 69:2043–2048CrossRefPubMed Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Kööbi T, Vaheri AI, Pasternack AI, Pörsti IH, Mustonen JT (2006) Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int 69:2043–2048CrossRefPubMed
20.
go back to reference Novo R, Gagnadoux MF, Le Guenno Y, Gubler MC, Niaudet P, Guyot C, Broyer M (1999) Chronic renal failure after Puumala virus infection. Pediatr Nephrol 13:934–935CrossRefPubMed Novo R, Gagnadoux MF, Le Guenno Y, Gubler MC, Niaudet P, Guyot C, Broyer M (1999) Chronic renal failure after Puumala virus infection. Pediatr Nephrol 13:934–935CrossRefPubMed
Metadata
Title
Favorable course of leptospirosis and hantavirus-induced acute tubulointerstitial nephritis under corticosteroid treatment
Authors
Annelies Matthys
Jo Dehoorne
Amélie Dendooven
Petra Schelstraete
Agnieszka Prytuła
Publication date
10-04-2023
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 11/2023
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-023-05942-w

Other articles of this Issue 11/2023

Pediatric Nephrology 11/2023 Go to the issue